Drug intelligence / Profile preview

mebeverine + simethicone

Development stage
Unknown
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

**Mebeverine + simethicone** is an oral fixed-dose combination of mebeverine hydrochloride, a myotropic gastrointestinal antispasmodic, and simethicone, a locally acting antifoaming agent. In the Phase 3 MESI3001 study, Abbott evaluated film-coated tablets containing 135 mg mebeverine and 80 mg simethicone three times daily for abdominal pain and bloating or flatulence associated with functional bowel disorders, including irritable bowel syndrome, chronic functional constipation, chronic functional diarrhea, and functional abdominal bloating. The combination is intended to reduce gastrointestinal smooth-muscle spasm and facilitate dispersion of intestinal gas bubbles. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05175131))

Brand names
Arluy Duo
Other names
mebeverine + simeticone
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on mebeverine + simethicone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mebeverine + simethicone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call